A novel doxorubicin-loaded in situ forming gel based high concentration of phospholipid for intratumoral drug delivery

Molecular Pharmaceutics

Volumn 11, Issue 10, 2014, Pages 3378-3385

  Wu, Wenqi ^a   Chen, Hui ^a   Shan, Fengying ^a   Zhou, Jing ^a   Sun, Xun ^a   Zhang, Ling ^b   Gong, Tao ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

doxorubicin; in situ forming gel; intratumoral injection; phospholipid; solid tumors

Indexed keywords

ALCOHOL; DOXORUBICIN; MEDIUM CHAIN TRIACYLGLYCEROL; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; GEL; HUMAN; HUMAN CELL; IN SITU FORMING GEL SYSTEM; IN VITRO STUDY; MALE; MCF 7 CELL LINE; MOUSE; NONHUMAN; SARCOMA; SARCOMA CELL LINE; SINGLE DRUG DOSE; SOLID; SUSTAINED RELEASE FORMULATION; TUMOR XENOGRAFT; VISCOSITY; ANIMAL; CHEMISTRY; INTRALESIONAL DRUG ADMINISTRATION; PROCEDURES;

ANIMALS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MCF-7 CELLS; MICE; PHOSPHOLIPIDS;

EID: 84904577848     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500019p     Document Type: Article

References (41)

1. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012 CA: Cancer J. Clin. 2012, 62 (1) 10-29
2. WHO. 10 facts on cancer; World Health Organization: Geneva, 2006.
3. WHO. Cancer control; World Health Organization: Geneva, 2006.
4. Chun, C.; Lee, S. M.; Kim, C. W.; Hong, K.-Y.; Kim, S. Y.; Yang, H. K.; Song, S.-C. Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics Biomaterials 2009, 30 (27) 4752-4762
5. Nsereko, S.; Amiji, M. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations Biomaterials 2002, 23 (13) 2723-2731
6. Hatefi, A.; Amsden, B. Biodegradable injectable in situ forming drug delivery systems J. Controlled Release 2002, 80 (1) 9-28
7. Anseth, K. S.; Metters, A. T.; Bryant, S. J.; Martens, P. J.; Elisseeff, J. H.; Bowman, C. N. In situ forming degradable networks and their application in tissue engineering and drug delivery J. Controlled Release 2002, 78 (1) 199-209
8. Liu, F.; Urban, M. W. Recent advances and challenges in designing stimuli-responsive polymers Prog. Polym. Sci. 2010, 35 (1) 3-23
9. Jeong, B.; Kim, S. W.; Bae, Y. H. Thermosensitive sol-gel reversible hydrogels Adv. Drug Delivery Rev. 2002, 54 (1) 37-51
10. He, C.; Kim, S. W.; Lee, D. S. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery J. Controlled Release 2008, 127 (3) 189-207
11. Kang, Y. M.; Kim, G. H.; Kim, J. I.; Kim, D. Y.; Lee, B. N.; Yoon, S. M.; Kim, J. H.; Kim, M. S. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly (ethylene glycol)-b-polycaprolactone diblock copolymer Biomaterials 2011, 32 (20) 4556-4564
12. Kang, Y. M.; Lee, S. H.; Lee, J. Y.; Son, J. S.; Kim, B. S.; Lee, B.; Chun, H. J.; Min, B. H.; Kim, J. H.; Kim, M. S. A biodegradable, injectable, gel system based on MPEG- b -(PCL- ran -PLLA) diblock copolymers with an adjustable therapeutic window Biomaterials 2010, 31 (9) 2453-2460
13. Kakinoki, S.; Taguchi, T.; Saito, H.; Tanaka, J.; Tateishi, T. Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: characterization and in vitro evaluation Eur. J. Pharm. Biopharm. 2007, 66 (3) 383-390
14. Al-Abd, A. M.; Hong, K.-Y.; Song, S.-C.; Kuh, H.-J. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice J. Controlled Release 2010, 142 (1) 101-107
15. Lee, J. Y.; Kim, K. S.; Kang, Y. M.; Kim, E.; Hwang, S.-J.; Lee, H. B.; Min, B. H.; Kim, J. H.; Kim, M. S. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth Int. J. Pharmaceutics 2010, 392 (1) 51-56
16. Liu, W.; MacKay, J. A.; Dreher, M. R.; Chen, M.; McDaniel, J. R.; Simnick, A. J.; Callahan, D. J.; Zalutsky, M. R.; Chilkoti, A. Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model J. Controlled Release 2010, 144 (1) 2-9
17. Shikanov, A.; Shikanov, S.; Vaisman, B.; Golenser, J.; Domb, A. J. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant Int. J. Pharmaceutics 2008, 358 (1) 114-120
18. Le Renard, P.-E.; Jordan, O.; Faes, A.; Petri-Fink, A.; Hofmann, H.; Rüfenacht, D.; Bosman, F.; Buchegger, F.; Doelker, E. The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia Biomaterials 2010, 31 (4) 691-705
19. Royals, M. A.; Fujita, S. M.; Yewey, G. L.; Rodriguez, J.; Schultheiss, P. C.; Dunn, R. L. Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys J. Biomed. Mater. Res. 1999, 45 (3) 231-239
20. Kranz, H.; Brazeau, G.; Napaporn, J.; Martin, R.; Millard, W.; Bodmeier, R. Myotoxicity studies of injectable biodegradable in-situ forming drug delivery systems Int. J. Pharmaceutics 2001, 212 (1) 11-18
21. Parent, M.; Nouvel, C.; Koerber, M.; Sapin, A.; Maincent, P.; Boudier, A. PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release J. Controlled Release 2013, 172 (1) 292-304
22. Packhaeuser, C.; Schnieders, J.; Oster, C.; Kissel, T. In situ forming parenteral drug delivery systems: an overview Eur. J. Pharm. Biopharm. 2004, 58 (2) 445-455
23. Elbert, D. L.; Pratt, A. B.; Lutolf, M. P.; Halstenberg, S.; Hubbell, J. A. Protein delivery from materials formed by self-selective conjugate addition reactions J. Controlled Release 2001, 76 (1) 11-25
24. Kumbhar, A. B.; Rakde, A. K.; Chaudhari, P. In situ gel forming injectable drug delivery system Int. J. Pharm. Sci. Res. 2013, 4 (2) 597-609
25. Tae, G.; Kornfield, J. A.; Hubbell, J. A. Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly (ethylene glycol) Biomaterials 2005, 26 (25) 5259-5266
26. Bajpai, A.; Shukla, S. K.; Bhanu, S.; Kankane, S. Responsive polymers in controlled drug delivery Prog. Polym. Sci. 2008, 33 (11) 1088-1118
27. Hong, D.-W.; Lai, P.-L.; Ku, K.-L.; Lai, Z.-T.; Chu, I. Biodegradable in situ gel-forming controlled vancomycin delivery system based on a thermosensitive mPEG-PLCPPA hydrogel Polym. Degrad. Stab. 2013, 98 (9) 1578-1585
28. Ding, H.; Wu, F.; Huang, Y.; Zhang, Z.-r.; Nie, Y. Synthesis and characterization of temperature-responsive copolymer of PELGA modified poly(N-isopropylacrylamide) Polymer 2006, 47 (5) 1575-1583
29. Ruel-Gariépy, E.; Leroux, J.-C. In situ-forming hydrogels-review of temperature-sensitive systems Eur. J. Pharm. Biopharm. 2004, 58 (2) 409-426
30. Camargo, J.; Sapin, A.; Nouvel, C.; Daloz, D.; Leonard, M.; Bonneaux, F.; Six, J.-L.; Maincent, P. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization Drug. Dev. Ind. Pharm. 2013, 39 (1) 146-155
31. Young, R. C.; Ozols, R. F.; Myers, C. E. The anthracycline antineoplastic drugs N. Engl. J. Med. 1981, 305 (3) 139
32. Kimura, M.; Takai, M.; Ishihara, K. Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels J. Biomed. Mater. Res. A 2007, 80 (1) 45-54
33. Schwab, M.; Kessler, B.; Wolf, E.; Jordan, G.; Mohl, S.; Winter, G. Correlation of in vivo and in vitro release data for rh-INFα lipid implants Eur. J. Pharm. Biopharm. 2008, 70 (2) 690-694
34. Montaguti, P.; Melloni, E.; Cavalletti, E. Acute intravenous toxicity of dimethylsulfoxide, polyethylene glycol 400, dimethyl-formamide, absolute ethanol, and benzyl alcohol in inbred mouse strains Arzneim.-Forsch. 1994, 44, 566-570
35. Alstota, R. L.; Tarrania, M. E.; Forney, R. B. The acute toxicities of 1-methylxanthine, ethanol and 1-methylxanthine/ethanol combinations in the mouse Toxicol. Appl. Pharmacol. 1973, 24 (3) 393-404
36. Malcolm, R. D.; Alkana, R. L. Temperature dependence of ethanol lethality in mice J. Pharm. Pharmcol 1983, 35 (5) 306-311
37. Liu, F.; Urban, M. W. Recent advances and challenges in designing stimuli-responsive polymers Prog. Polym. Sci. 2010, 35 (1-2) 3-23
38. Packhaeuser, C. B.; Schnieders, J.; Oster, C. G.; Kissel, T. In situ forming parenteral drug delivery systems: an overview Eur. J. Pharm. Biopharm 2004, 58 (2) 445-455
39. Kempe, S.; Mäder, K. In situ forming implants-an attractive formulation principle for parenteral depot formulations J. Controlled Release 2012, 161 (2) 668-679
40. Hyun, H.; Kim, Y. H.; Song, I. B.; Lee, J. W.; Kim, M. S.; Khang, G.; Park, K.; Lee, H. B. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier Biomacromolecules 2007, 8 (4) 1093-1100
41. Ding, H.; Wu, F. Image guided biodistribution and pharmacokinetic studies of Theranostics Thera'ostics 2012, 2 (11) 1040